MANITIMUS
UNII 4B135RK2KL

Substance Identification & Data

This profile provides standardized clinical and technical data for Manitimus, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4B135RK2KL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 202057-76-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4B135RK2KL

CAS Registry Number

202057-76-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MANITIMUS

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C15H11F3N2O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IRELROQHIPLASX-SEYXRHQNSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C83901

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

54686843

Unique identification number in the NCBI database of chemical substances.

INN ID

8596

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cc(ccc1NC(/C(=C(/CCC#C)\O)/C#N)=O)C(F)(F)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Manitimus. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.